C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,049,362 | +6.2% | 177,858 | +57.9% | 0.01% | -18.2% |
| Q3 2022 | $988,000 | -69.9% | 112,650 | -16.8% | 0.01% | -42.1% |
| Q1 2022 | $3,285,000 | +10.9% | 135,392 | +47.2% | 0.02% | +18.8% |
| Q4 2021 | $2,963,000 | +12.3% | 92,007 | +55.8% | 0.02% | -11.1% |
| Q3 2021 | $2,638,000 | +42.7% | 59,051 | +20.9% | 0.02% | +50.0% |
| Q2 2021 | $1,848,000 | +6.5% | 48,833 | +4.1% | 0.01% | 0.0% |
| Q1 2021 | $1,735,000 | – | 46,906 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |